![](/img/cover-not-exists.png)
The Early Glycoprotein IIb/IIIa Inhibition in Non–ST-Segment Elevation Acute Coronary Syndrome (EARLY ACS) trial: A randomized placebo-controlled trial evaluating the clinical benefits of early front-loaded eptifibatide in the treatment of patients with non–ST-segment elevation acute coronary syndrome—Study design and rationale
Robert P. Giugliano, L. Kristin Newby, Robert A. Harrington, C. Michael Gibson, Frans Van de Werf, Paul Armstrong, Gilles Montalescot, James Gilbert, John T. Strony, Robert M. Califf, Eugene BraunwaldVolume:
149
Year:
2005
Language:
english
Pages:
1003
DOI:
10.1016/j.ahj.2005.03.029
File:
PDF, 148 KB
english, 2005